Determination by high-performance liquid chromatography with electrochemical detection of free and conjugated N-acetyldopamine excretion in urine of children with neuroblastoma and nephroblastoma

https://doi.org/10.1016/0378-4347(92)80092-5Get rights and content

Abstract

A simple method for the determination of N-acetyldopamine (NADA) (both free and conjugated) in children's urine by high-performance liquid chromatography with electrochemical detection has been developed. Conjugated NADA was measured as the free compound after enzymatic hydrolysis and purification on alumina. The total analysis time is 25 min. The results show a linearity of the whole assay from 0.005 to 20 μmol/l NADA; the sensitivity is 0.2 pmol per 20 μl injected sample. Mean recoveries of 96.7 and 86.6% were obtained for free and total NADA, respectively. Modifications of the retention times (between 2 and 50 min) induced by changes in the eluent were determined. Conjugated NADA accounted for about 90% of the total excretion of NADA. These results suggest that this compound could play an important part in neuroblastoma; its concentration is thirteen times higher in children with neuroblastoma than in normal subjects.

References (23)

  • S. Hayashi et al.

    Comp. Biochem. Physiol. C

    (1977)
  • D. Omar et al.

    J. Chromatogr.

    (1981)
  • A. Hanson et al.

    Clin. Chim. Acta

    (1965)
  • M. Goldstein et al.

    Biochim. Biophys. Acta

    (1962)
  • G.M. Tyce

    Biochem. Pharmacol.

    (1971)
  • M.W. McCaman et al.

    Anal. Biochem.

    (1979)
  • S.J. Saul et al.

    FEBS Lett.

    (1989)
  • R.G.H. Downer et al.

    Life Sci.

    (1987)
  • M.A. Elchisak et al.

    J. Chromatogr.

    (1982)
  • N.D. Vlachakis et al.

    Clin. Chim. Acta

    (1984)
  • P. Mathieu et al.

    Biochem. Pharm.

    (1976)
  • Cited by (6)

    • Methenyltetrahydrofolate synthetase is a high-affinity catecholamine-binding protein

      2006, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      The biological origin and physiological role of NADA is not known, but N-acetyltransferase 2 (NAT2) is capable of acetylating dopamine to NADA [31,32]. Urinary NADA concentrations are elevated in individuals treated with monoamine oxidase inhibitors [36], and children with neuroblastomas and nephroblastomas display 13- and 4-fold, respectively, higher levels of urinary NADA compared to unaffected individuals [36,37]. The effect of elevated NADA on whole-body folate status in these patients has not been examined, although folate deficiency is commonly observed in a number of cancer models [7].

    • Allele NAT2*5 determines resistance to bronchial asthma in children

      2000, Bulletin of Experimental Biology and Medicine
    • Electroanalysis and Biosensors

      1993, Analytical Chemistry
    View full text